27 February 2023: Interim report for 2nd half year and full-year 2022
28 April 2023: Annual Report for 2022
22 May 2023: Annual General Meeting
MEET US AT
May 19: Assoc. Prof. Marco Bortolato (Dept Pharmacology & Toxicology, University of Utah) presents Asarina Pharma’s Phase IIa results at TicCon – the Virtual National Conference of the Tourette Association of America, at 9.30 PM CET. His presentation is titled: ‘Putative novel pharmacological treatments for tic disorders’. Register here: https://touretteconference.org/en/registration
June 5-8: CEO Peteer Nordkild and Business Development Officer Otto Skolling attend BIO 2023, Boston International Convention Center, Boston Mass. US. Register here: https://www.bio.org/events/bio-international-convention
June 7-9: CEO Peter Nordkild presents the full Phase IIa data at EESTS, the 15th European Conference on Tourette Syndrome and Tic Disorders in Brussels Belgium. Register for the event here: https://www.essts.org/registration
Follow us on our social media channels as we post on each event.